1.Closure of Patent Arterial Duct Using Hem-o-lok Polymer Ligating Clip
Xiaobin LIN ; Jian LIU ; Jixiu HUANG
Chinese Journal of Minimally Invasive Surgery 2005;0(07):-
Objective To report our experience on closure of patent arterial duct using Hem-o-lok polymer ligating clip under a direct vision.Methods From May 2001 to May 2007,84 patients with cast patent arterial duct were treated with Hem-o-lok polymer ligating clips.Under a direct vision,the clips were placed to close the patent arterial duct through a small left subaxillary incision.Results The mean operation time was 42 minutes(ranged from 30 to 60).No intraoperative bleeding occurred in this series.After the operation,heart murmur disappeared in all the patients and none of them died.They were followed up for 2 to 50 months(mean 28 months),during which no residual shunting or recanalization occurred.Conclusion It is microinvasive and safe to close patent arterial duct by using Hem-o-lok polymer ligating clip.
2.Influencing factors and outcomes of atrial septal defect or ventricular septal defect occlusion guided by echocardiography
LIU Jian ; TANG Xiancheng ; HUANG Jixiu ; LIN Xiaobin
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2018;25(12):1060-1063
Objective To analyze the influencing factors and outcomes of atrial septal defect (ASD) and ventricular septal defect (VSD) occlusion guided by echocardiography. Methods We retrospectively analyzed the clinical data of 188 patients receiving transthoracic and percutaneous transcatheter closure of ASD and VSD from July 2009 to July 2017 in our department, including 74 males and 114 females, aged 13.48±13.53 years ranging from 1 to 65 years. Results Fifty-three ASD patients accepted transthoracic closure surgery, of whom 4 patients were difficult to close and 6 patients failed to close; 24 patients underwent percutaneous transcatheter ASD occlusion surgery, of whom 3 were difficult to close and 1 failed in occlusion; 108 VSD patients implemented transthoracic closure surgery, of whom 10 patients were difficult to close and 5 patients failed in closure; 9 VSD patients underwent percutaneous transcatheter closure, of whom 5 failed and then was converted to transthoracic closure. Our study showed that too large or too small aperture was the independent risk factor. Two kinds of closure surgery had their own advantages and disadvantages. The special type of VSD was the influencing factor of transthoracic closure. Conclusion When the ASD diameter≥25 mm, transthoracic closure is the best choice to avoid the use of large occluder. When the ASD diameter<25 mm, percutaneous closure surgery is the best choice. When the ASD diameter≥35 mm, it is best to give up the closure operation. Technical improvements can significantly raise the closure success rate of the subarterial VSD. For the entry diameter>10 mm and membranous aneurysm with multi-break, occlusion surgery should be avoided in VSD.